AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. With its headquarters in the UK, the company employs over 190 staff globally and has support offices worldwide.
Assess feed quality to make smarter nutritional and commercial decisions.
Measure enzyme activity to ensure consistent quality control.
Optimise the feed manufacturing process.
AB Vista is committed to facilitating discussions around animal nutrition technology and gathering experts to provide independent opinions. Our ultimate aim is to research and apply science that brings real value commercially to the animal production industry.
Stay ahead with the latest news, ideas and events.
AB Vista is committed to bringing new ways of thinking to the global feed industry. Our work attracts enquiring minds who see things differently and embrace the changing landscape – offering our clients an interested, innovative and up-to-date partner.
Tuesday, February 16, 2016
AB Vista has appointed a new Technical Sales Manager to its Former Soviet Union region, as it continues to expand its product and service offering in the emerging market.
READ MORE ▶
Thursday, January 28, 2016
Richard Cooper, Hadden Graham and Mike Bedford discuss some of the key focus areas of development for the future within animal nutrition technology, highlighting the potential impact for customers and the marketplace.
In a recently released technical video, Mike Bedford, Research Director at AB Vista, highlights new research that more precisely identifies how phytases work in the animal.
Monday, January 25, 2016
Superdosing – where are the benefits coming from? Part one: complete phytate destruction
Thursday, January 21, 2016
New research from AB Vista shows that thermostability of xylanase plays a critical role in ensuring consistent performance improvements in poultry.
A regular summary of our key stories sent straight to your inbox.
Subscribe
Receive a regular summary of our key stories sent straight to your inbox.
A regular summary of our key stories sent straight to your inbox